# Nuo Therapeutics, Inc.: Form SC 13D/A, filed Jul 5, 2022

- Company: [Nuo Therapeutics, Inc.](/companies/aurx.md) (CIK 1091596)
- Form: SC 13D/A
- Filed: 2022-07-05
- Accepted by EDGAR: Jul 5, 2022, 12:02 ET
- Period: not reported
- Accession: 0001437749-22-016504
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1091596/000143774922016504/shee20220629_sc13da.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1091596/000143774922016504/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1091596/000143774922016504/shee20220629_sc13da.htm

Filed Jul 5, 2022.
Source: SEC EDGAR, the filing index for accession 0001437749-22-016504. Last ingested by Listed: Oct 24, 2026, 15:02 ET. No prices; not investment advice.
